Toxoplasmosis - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Toxoplasmosis - Pipeline Review, H1 2016

Toxoplasmosis - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Toxoplasmosis - Pipeline Review, H1 2016
Published Jun 08, 2016
32 pages — Published Jun 08, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Toxoplasmosis - Pipeline Review, H1 2016, provides an overview of the Toxoplasmosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Toxoplasmosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Toxoplasmosis and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Toxoplasmosis
- The report reviews pipeline therapeutics for Toxoplasmosis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Toxoplasmosis therapeutics and enlists all their major and minor projects
- The report assesses Toxoplasmosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Toxoplasmosis

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Toxoplasmosis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Toxoplasmosis pipeline depth and focus of Indication therapeutics
- Develop and design in

  
Source:
Document ID
GMDHC8210IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Toxoplasmosis Overview61
Therapeutics Development72
  Pipeline Products for Toxoplasmosis Overview71
  Pipeline Products for Toxoplasmosis Comparative Analysis81
Toxoplasmosis Therapeutics under Development by Companies91
Toxoplasmosis Therapeutics under Investigation by Universities/Institutes101
Toxoplasmosis Pipeline Products Glance111
  Early Stage Products111
Toxoplasmosis Products under Development by Companies121
Toxoplasmosis Products under Investigation by Universities/Institutes131
Toxoplasmosis Companies Involved in Therapeutics Development141
  Turing Pharmaceuticals AG141
Toxoplasmosis Therapeutics Assessment157
  Assessment by Monotherapy Products151
  Assessment by Target162
  Assessment by Mechanism of Action182
  Assessment by Molecule Type202
Drug Profiles228
  Monoclonal Antibody for Toxoplasmosis - Drug Profile221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  Polysaccharide for Oncology, Infectious Disease and Allergy - Drug Profile231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  Small Molecule to Inhibit Histone Deacetylase for Toxoplasmosis and Other Parasitic Diseases - Drug Profile241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  Small Molecules for Toxoplasmosis - Drug Profile251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  toxoplasmosis vaccine - Drug Profile261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  toxoplasmosis vaccine - Drug Profile271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  toxoplasmosis vaccine - Drug Profile281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  TRP-004 - Drug Profile291
    Product Description291
    Mechanism of Action291
    R&D Progress291
Toxoplasmosis - Dormant Projects301
Appendix312
  Methodology311
  Coverage311
  Secondary Research311
  Primary Research311
  Expert Panel Validation311
  Contact Us311
  Disclaimer321

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Toxoplasmosis - Pipeline Review, H1 2016" Jun 08, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Toxoplasmosis-Pipeline-Review-H1-2016-2088-15931>
  
APA:
Global Markets Direct - Market Research. (2016). Toxoplasmosis - Pipeline Review, H1 2016 Jun 08, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Toxoplasmosis-Pipeline-Review-H1-2016-2088-15931>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.